Contraceptive Drugs Market to Reach Valuation of USD 16.5 Billion by 2028 – Increasing Awareness About Birth Control Drives the Market
In terms of revenue, the Global Contraceptive Drugs Market is expected to reach USD 16.5 Billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 5.4% from 2022 to 2028.
The increasing awareness about birth control, government initiatives, and increased use of oral pills are anticipated to augment the growth of the market during the forecast period.
Key Highlights from Report:
- Under the age group segment, the 15–24 years sub-segment held the target share for the segment for the Contraceptive Drugs Market. This dominance is attributed to factors such as augmented use of contraceptives among teenagers, early maturity among teenage girls, and an increase in demand for contraceptives across the globe.
- Under the End-User segment, the homecare segment sub-segment held the target share for the segment for the Contraceptive Drugs Market. This dominance is attributed to factors such as wide consumption of oral pills to prevent unplanned pregnancy and STIs and an Increase in the use of Contraceptive Drugs at home.
- Asia Pacific is expected to grow at the fastest Compound Annual Growth Rate (CAGR) during the forecast period. The huge population and government initiatives for birth control and increased awareness will support market growth in this region.
Contraception is a method of controlling the birth rate and unwanted pregnancy and also reducing the risk of diseases like STD which stands for sexually transmitted disease. Contraception drugs are taken orally this drug are used by women who avoid unwanted pregnancy. this drug is not only used for birth control but also for reducing the risk of sexually transmitted diseases. Government activity like launching new Contraceptive Drugs, at low cost will support market growth. Rising awareness about family planning and the use of birth control pills has increased over the past few years. During the lockdown, this market growth was hampered as women were unable to purchase pills or visit a healthcare center.
North America held the largest shares in 2021. The U.S. held the largest share in North America for the Contraceptive Drugs Market. Awareness about birth control pills in this region and the adoption of Contraceptive Drugs drive the market growth in this region.
The Contraceptive Drugs is segmented as follows:
Browse market data Tables and Figures
Pages and in-depth TOC on "Contraceptive Drugs Market Size, Share & Trends Analysis Report by Product (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives), by Age Group (15–24 years, 25–34 years, 35–44 years, Above 44 years), by End User (Homecare, Hospitals, Clinics), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)"
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of MEA
Vantage Market Research is a reputed company committed to providing high quality data and market research services. The company provides quantified B2B high quality research on more than 20,000 emerging markets. The company offers detailed reports on multiple industries including chemical materials and energy, food and beverages, healthcare, technology, etc. The company comprises over 125 analysts and consultants, adding more than 1,100 market research reports to its vast database every year. The company’s clientele base spans across 70% of the Global Fortune 500 companies.